Identifying Kinase Inhibitors that Modulate the Thymocyte Response to Strong TCR Signals

Begin with mice thymocyte cells in a multi-well plate. Add magnetic beads coated with anti-CD3 and anti-CD28 antibodies. To a subset of wells, add an appropriate concentration of the test kinase inhibitor. Incubate.

The antibodies bind to the cell-surface CD3 and CD28 receptors on the double-positive thymocytes and activate them, causing downregulation of T cell receptors, TCRs, and activation of cytosolic protein kinase.

These protein kinases activate downstream signaling pathways, leading to increased cell-surface CD69 expression and cytosolic caspase-3 activation. Activated caspase-3 cleaves essential cellular proteins — initiating thymocyte apoptosis.

In cells treated with the kinase inhibitor, the inhibitors block the cytosolic kinases, modulating CD69 expression and caspase-3 activation.

Pipette in a fluorophore-tagged antibody cocktail that binds to the thymocytes' TCR, CD4, and CD8 co-receptors, and CD69 receptors. Treat the thymocytes with a buffer to fix and permeabilize them.

Incubate with a fluorophore-tagged anti-caspase-3 antibody that binds to cytosolic caspase-3. Analyze the thymocytes using flow cytometry.

Control double-positive thymocytes express the fluorescent